Literature DB >> 24419388

Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interaction.

Jinsai Shang1, Guan Wang1, Yang Yang1, Xiaolan Huang2, Zhihua Du1.   

Abstract

The FP (Fbxo7/PI31) domains found in the F-box protein Fbxo7 and the proteasome inhibitor PI31 mediate the homodimerization and heterodimerization of Fbxo7 and PI31. Fbxo7 is the substrate-recognition subunit of the SCF(Fbxo7) (Skp1-Cul1-F-box protein) E3 ubiquitin ligase that catalyzes the ubiquitination of hepatoma up-regulated protein (HURP) and inhibitor of apoptosis protein (IAP). Fbxo7 also interacts with proteins that are not substrates of the ubiquitin proteasome system, such as Cdk6 and PI31. Here, the crystal structure of the Fbxo7 FP domain is reported at 2.0 Å resolution. The Fbxo7 FP domain adopts an α/β-fold similar to that of the PI31 FP domain. However, an α-helix and three β-strands in the Fbxo7 FP domain are longer than their counterparts in the PI31 FP domain. The differences in these secondary-structural elements are spatially clustered to define a more structured and extended C-terminal end of the Fbxo7 FP domain. The two FP domains also differ substantially in the length and conformation of the longest connecting loop. More importantly, structural differences between the two FP domains lead to drastically different modes of inter-domain protein-protein interaction. The inter-domain interface of the Fbxo7 FP domain is defined by the α-helical surface in one protomer and the β-sheet surface in the other protomer, whereas for the PI31 domain it is defined by either the α-helical surfaces or the β-sheet surfaces in both protomers. The inter-domain interaction of the Fbxo7 FP domain is much more extensive, featuring a larger contact surface area, better shape complementarity and more hydrophobic and hydrogen-bonding interactions. The Fbxo7 FP domain also has the potential to bind two protein partners simultaneously using the α-helical and β-sheet surfaces. The results of this structural study provide critical insights into how Fbxo7 may dimerize (or multimerize) and interact with other regulatory proteins via the FP domain.

Entities:  

Keywords:  F-box; Fbxo7; Fbxo7/PI31 domain; PI31 proteasome inhibitor; SCF E3 ubiquitin ligase

Mesh:

Substances:

Year:  2013        PMID: 24419388     DOI: 10.1107/S1399004713025820

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

Review 1.  Spo0M: structure and function beyond regulation of sporulation.

Authors:  Luz Adriana Vega-Cabrera; Christopher D Wood; Liliana Pardo-López
Journal:  Curr Genet       Date:  2017-06-02       Impact factor: 3.886

2.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

3.  Expression, purification and crystallization of the SKICH domain of human TAX1BP1.

Authors:  Yang Yang; Guan Wang; Xiaolan Huang; Zhihua Du
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-04-15       Impact factor: 1.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.